News
Cancer HorizonsAll NewsBlogsCaregivingDiet and ExerciseFinancialPsychosocialRecipesSexual HealthSide EffectSponsoredSurvivorship
Videos
All VideosCURE ConnectionsCURE Expert Connections®CURE Speaking OutCURE TVEducated Patient Sound BitesOn Demand: Webinars
Conferences
Conference Coverage Conference Listing
Events
CURE AdventuresCURE AwardsEducated Patient In Person EducationEducated Patient Virtual Education
More
Resources
Advocacy GroupsArt GalleryClinical Trial CornerHeal®PartnersPodcastsPublicationsShare Your Story

Subscribe

  • News
  • Videos
  • Conferences
  • Events
  • Resources
  • Subscribe
  • Blood Cancers
    • MPN
    • MDS
    • Myeloma
  • Brain Cancer
  • Breast Cancer
    • Metastatic Breast Cancer
  • Childhood Cancers
  • Gastrointestinal Cancers
    • Colorectal Cancer
    • Esophageal Cancer
    • Gastrointestinal stromal tumor
    • Liver Cancer
    • Pancreatic Cancer
  • Genitourinary Cancers
    • Bladder Cancer
    • Kidney Cancer
    • Prostate Cancer
  • Gynecologic Cancer
    • Cervical Cancer
    • Ovarian Cancer
  • Head & Neck Cancer
  • Leukemia
    • Acute Myeloid Leukemia
    • CLL
  • Lung Cancer
  • Lymphoma
    • Follicular Lymphoma
    • Mantle Cell Lymphoma
    • Non-Hodgkin Lymphoma
  • Rare Cancers
    • Neuroendocrine Cancer
  • Sarcoma
  • Skin Cancer/Melanoma
  • Thyroid Cancer
Spotlight -
Blogs|
Breast Cancer Webinar Series|
Cancer Horizons|
Clinical Trial Corner|
Heal®|
Publications|
Videos
Advertisement
|Videos|June 29, 2022

Future Perspectives in Renal Cell Carcinoma (RCC)

Author(s)Thomas Hutson, DO, PharmD

Dr Thomas Hutson comments on the TiNivo-2 trial and discusses upcoming and novel therapies for patients with renal cell carcinoma.

Advertisement

Episodes in this series

EP. 1 Treatment Options for Patients with Renal Cell Carcinoma (RCC)
EP. 1 Treatment Options for Patients with Renal Cell Carcinoma (RCC)
EP. 2 Clinical Implications of the TIVO-3 Trial
EP. 2 Clinical Implications of the TIVO-3 Trial
EP. 3 Tivozanib: Adverse Event Profile and How Toxicities are Managed
EP. 3 Tivozanib: Adverse Event Profile and How Toxicities are Managed
EP. 4 Experience with Tivozanib in the 3rd Line Setting for Patients with RCC
EP. 4 Experience with Tivozanib in the 3rd Line Setting for Patients with RCC
EP. 5 Future Perspectives in Renal Cell Carcinoma (RCC)
Now Playing
EP. 5 Future Perspectives in Renal Cell Carcinoma (RCC)

Newsletter

Stay up to date on cancer updates, research and education

Subscribe Now!
Advertisement

Related Content

Advertisement
kidney cancer

Fruzaqla and Tyvyt Combo Shows Improved Outcomes in Advanced Kidney Cancer

ByRyan Scott
October 14th 2025
Dr. Ravi Munver

Helping Patients Understand the Evolving Landscape of Kidney Cancer Treatment

ByRyan Scott
October 11th 2025
Image of man.

Minimally Invasive Kidney Cancer Treatments Boosts Patient Recovery

ByDr. Ravi Munver
October 9th 2025
Image of woman.

How Can Remote Monitoring Help Patients After Cancer Surgery?

ByAlex Biese
October 8th 2025
Image of organs.

Top Genitourinary Cancer Stories From September to Know

ByRyan Scott
October 4th 2025
Advertisement
Advertisement

Trending on CURE

1

Verzenio Plus Endocrine Therapy Benefits Survival for Some With Breast Cancer

2

Stage 1 Multiple Myeloma Treatment Options and Side Effect Management

3

Buparlisib Plus Chemo Fails to Improve Head and Neck Cancer Survival

4

Stem Cell Transplant: Why This Treatment Is Still a ‘Standard Regimen’ for Blood Cancer

5

Trodelvy Plus Keytruda Upholds Quality of Life in TNBC

  • About Us
  • Advertise / Support
  • Editorial Board
  • Contact Us
  • CancerNetwork.com
  • TargetedOnc.com
  • OncLive.com
  • OncNursingNews.com
  • Terms & Conditions
  • Privacy
  • Do Not Sell My Information
  • Washington My Health My Data
Contact Info

259 Prospect Plains Rd, Bldg H
Cranbury, NJ 08512

609-716-7777

Brand Logo

© 2025 MJH Life Sciences®

All rights reserved.